Greater autonomy at the point of care with a customized solution

With QuoreOne, the doctor prescribes continuous tests for up to 7 days, tailoring the cardiac monitoring time to the type of diagnosis the patient requires.

Get a solution adapted to your needs

Schedule a free consultation

Create events, manage exams and configure the device

Download the app from the stores:

Create events, manage exams and configure the device

Download the app from the stores:

We want to revamp cardiac monitoring

Around 33% of cases of atrial fibrillation are asymptomatic, which makes it increasingly necessary to have an easy and effective way of diagnosing these patients.

20%

THE CASES

They are estimated not to have been diagnosed in older patients.6,7

20

MILLIONS

Brazilian population with some type of arrhythmia2

2

MILLIONS

Holter tests

performed per year.3,8,9

40

MIL

potential undiagnosed population in the last 5 years.3

Wearable solution that brings practicality and quality to exams

Long-term monitoring

Increases the diagnostic rate of clinically significant arrhythmias by up to 2x compared to 24-hour tests3

Instant capture

The patient's app captures heart signals in real time via Bluetooth.

AI analysis

It identifies rhythm abnormalities that are invisible to the human eye, such as Atrial Fibrillation.

Get a solution tailored to your needs.

Schedule a free consultation

The right solution for any type of health care center

Clinics;
Polyclinics;
Hospitals;
Specialized clinics;
Diagnostic centers.

Get a solution tailored to your needs.

Schedule a free consultation

Artificial Intelligence to improve diagnostic efficiency

Get a solution tailored to your needs.

Schedule a free consultation

It helps analyze and group signals, detecting patterns and anomalies in ECG data.

It allows large amounts of data to be analyzed quickly and patterns and trends indicative of arrhythmias to be identified.

With 3 derivations, it captures three times more data than competitors who use a single derivation.

Short- and long-term tests in a single solution

QuoreOne provides long-term cardiac monitoring of up to 7 days, as well as allowing events to be scheduled. In a single technology, it gives the doctor flexibility to diagnose different patient profiles:

Arrhythmias

Cryptogenic stroke

Pacemaker

Post-procedures where there may be a change in heart rhythm

Short- and long-term tests in a single solution

QuoreOne provides long-term cardiac monitoring of up to 7 days, as well as allowing events to be scheduled. In a single technology, it gives the doctor flexibility to diagnose different patient profiles:

Arrhythmias

Cryptogenic stroke

Pacemaker

Post-procedures where there may be a change in heart rhythm

Hospital

"Inpatients find the device more practical and it has made life much easier for the staff."

Dra Adriana Bertolami

Cardiologist

Alma Cardio Clinic

Hospital

"For those looking for a way to simplify the entire Holter diagnostic process. State-of-the-art technology, accurate diagnosis and super comfortable for the patient."

Dra. Gabriela Hinkelmann Berbert

Cardiologist and Electrophysiologist

IDPC Hospital

Doctor's Office

"The examination of more than 48 hours allows me a more in-depth diagnosis, which has already allowed me to identify abnormalities that led the patient to a timely procedure."

Dr Carlo Bonasso

Cardiologist

Medical

"An innovative solution that changes the way electrocardiographic exams are carried out, in a precise, efficient and comfortable way for the patient."

Dr. Rodrigo Bornhausen Demarch

Doctor and entrepreneur

Diagnostic Center

"This is a modern information transmission system, which avoids signal problems and interference; from a medical point of view, it expands the possibilities for diagnosis, allowing an efficient, accurate and faster report."

Dra. Paola Smanio

Cardiologist

Fleury Group

Medical

"An advanced continuous electrocardiographic monitoring system that allows the recording of cardiac electrical activity in real time, ideal for identifying causes of syncope. This really is a breakthrough in cardiology."

Dr. Dalmo Antonio Ribeiro Moreira

Head of Electrophysiology

IDPC Hospital

Clinic

"Today we have the most modern and comfortable holter on the market. In 3 months of operation, we've increased our examination capacity by 40% with a 20% reduction in installation time."

Cristina Pedrassi

Administrator

Lapacor Clinic

QuoreOne is much more than a device, we bring you a totally innovative experience in use and acquisition

With no initial investment, payment per test performed and device subscription, you have access to a digital solution with qualitative and quantitative gains.

With QuoreOne

WithOut QuoreOne

With QuoreOne

Digital Technology

No cables or batteries;

Online exam transmission;

Prolonged monitoring of up to 7 days;

Artificial intelligence analysis.

Acquisition on demand

Choose subscription by number of devices;

Choose the exam production plan;

Receive devices + charger at no additional cost;

Pays per exam performed.

Business consultancy

Customer understanding meeting;

Customized proposal to the needs presented;

Training on installation and use of the cloud platform;

Support with educational material.

WithOut QuoreOne

Analog technology

With cables or batteries;

Offline exam transmission;

Monitoring for up to 3 days;

Analysis on a web platform.

Acquisition on purchase

Purchase the device and platform license;

Decapitalization;

Receive the device at shipping cost;

Maintenance cost (cables, batteries, belts, calibration).

Why buy when you can subscribe and pay per use?

You don't have to spend a lot of money to have short and long-term cardiac monitoring technology in your healthcare facility.

Monthly subscription

by device

It brings more practicality and availability, without worrying about maintaining cables, batteries and SD cards. You pay the subscription and get full support.

Implementing the technology

Upgrading technology

Replacement devices

Secure data storage

Technical support

Installation training

Platform training

Get a solution adapted to your needs

Schedule a free consultation

Choose the plan that best suits your needs

Customize our service to the dynamics of your health establishment, paying only for the tests you perform.

STANDARD

PREMIUM

REFERENCES ON THIS PAGE

2 - J.L. CLUA-ESPUNY ET AL. PREVALENCE OF UNDIAGNOSED ATRIAL FIBRILLATION AND OF THAT NOT BEING TREATED WITH ANTICOAGULANT DRUGS: THE AFABE STUDY , REV ESP CARDIOL. 2013;66(7):545–552

3 - Parikh P., et al, Diagnostic Yield of 24-hour Holter vs 7-day and 14-day epatch extended wear Holter, J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 149

6 - SBC, II Diretrizes Brasileiras de Fibrilação Atrial, Volume 106, No. 4, Supl. 2, Abril 2016

7 - SOBRAC, CAMPANHA CORAÇÃO NA BATIDA CERTA: BRASIL EM AÇÃO PELA PREVENÇÃO E TRATAMENTO DAS ARRITMIAS CARDÍACAS E MORTESÚBIA, [https://sobrac.org/home/campanha-coracao-na-batida-certa-brasil-em-acao-pela-prevencao-e-tratamento-das-arritmias-cardiacas-emorte-subia/]
8 - ANS [https://www.gov.br/ans/pt-br/acesso-a-informacao/perfil-do-setor/dados-e-indicadores-do-setor]
9 - SUS [http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sia/cnv/qauf.def]

10 - Kornej J., ET AL, Epidemiology of Atrial Fibrilation in the 21st Century - Novel Methods and New Insights, Circulation Research. 2020; 127;4-20. DOI: 10.1161/Circresaha. 120.31634

Wearable solution that brings practicality and quality to exams